Jason Kelly, Ginkgo Bioworks CEO (Photographer: Adam Glanzman/Bloomberg via Getty Images)

Gink­go Bioworks nets sec­ond con­tract with Mer­ck

Gink­go Bioworks se­cured an­oth­er man­u­fac­tur­ing deal with Mer­ck, this time cen­tered around im­prov­ing bi­o­log­ic man­u­fac­tur­ing.

Ac­cord­ing to a re­lease on Mon­day, Gink­go said that it plans to help Mer­ck’s pro­duc­tion be­come more ef­fi­cient and in­crease out­put. Gink­go may be able to net a to­tal of $490 mil­lion in re­search fees, mile­stone pay­ments, hit­ting com­mer­cial tar­gets and re­ceiv­ing op­tion li­cense pay­ments.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.